Feb 13 (Reuters)-
Delta-Fly Pharma, Inc.
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
9 months ended 9 months ended Year to
Dec 31, 2025 Dec 31, 2024 Mar 31, 2026
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Operating loss 1.23 loss 1.29 loss 1.50
Recurring loss 1.25 loss 1.31 loss 1.51
Net loss 1.25 loss 1.31 loss 1.51
EPS loss 110.72 yen loss 153.93 yen loss 155.45 yen
Ann Div NIL NIL
-Q2 div NIL NIL
-Q4 div NIL NIL
NOTE - Delta-Fly Pharma, Inc..
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4598.T